NRD
CME icon

Nebula Research & Development’s CME Group CME Stock Holding History

Nebula Research & Development’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,599
Closed -$992K – 182
2025
Q2 		$992K Buy
+3,599
New +$979K 0.08% 402
2024
Q3 		– Sell
-12,722
Closed -$2.5M – 961
2024
Q2 		$2.5M Buy
12,722
+10,677
+522% +$2.21M 0.41% 17
2024
Q1 		$440K Buy
2,045
+270
+15% +$56.7K 0.09% 402
2023
Q4 		$374K Buy
1,775
+387
+28% +$82.6K 0.11% 355
2023
Q3 		$278K Buy
+1,388
New +$276K 0.15% 297

Other funds holding CME

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nebula Research & Development's CME Position: Q3 2025 in Review

Nebula Research & Development sold out of CME Group (CME) in Q3 2025, closing a stake of 3,599 shares — an estimated $992K sold.

Nebula Research & Development first reported a position in CME in Q3 2023 and held it in 5 quarters. The position peaked at $2.5M in Q2 2024. 1,653 funds tracked by Wall St. Rank hold CME as of Q3 2025.

  • Nebula Research & Development reported no remaining CME Group position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 3,599 CME Group shares in Q3 2025, an estimated $992K.
  • Nebula Research & Development first reported a position in CME Group in Q3 2023 and held it in 5 quarters.
  • Nebula Research & Development's CME Group position peaked at $2.5M in Q2 2024.
  • 1,653 funds tracked by Wall St. Rank held CME Group as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.